Aim: Assess the influence of tobacco on recovery after exercise in sportsmen.
Methods: Sixty-three smokers aged 18-33 years, practising soccer, participated in this study. These subjects belonged to second division congolese league clubs. Heart rate (HR) was studied during recovery of moderate exercise (Ruffer's test), but also recovery index and arterial pressure. Kinetics of the HR was studied for 7 min for recovery. A control group consisted of 50 non smokers, practising soccer at similar level.
Results: Smokers showed heart rate values significantly higher (P < 0.001). Non smokers presented a low recovery index. The recovery has generally two components: the first is slow in smokers, while the second is a fast one. However, recovery rate for the smokers was more rapid during the alactic phase. There exists also differences with regards to smoking tobacco dependence: when compared to great smokers, lower smokers exhibited a faster first phase and a slower second phase. These differences were significant.
Discussion And Conclusion: The smokers and non smokers differences are discussed with reference to the effects of nicotinemia and carbon monoxide on sympathetic-parasympathetic balance. Cardiovascular changes during exercise have a twofold control: decrease a vagal tone and increase of sympathetic activity. The comparison of smokers and non smokers concerning recovery led to suppose that there exists a difference in regards of the catecholaminergic sensitivity. The problem of thermoregulation must not be neglected during recovery. As smokers are considered, cutaneous thermolysis is perhaps important when these subjects perform exercise in ambient hot air. Here against, it is known that thermolysis mechanisms are not similar in smokers and non smokers. In conclusion, this study showed that smoking tobacco induce a lower physical condition in sportmen. Recovery rate after exercise may function as a predictor of fitness in smokers.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0003-3928(02)00146-4 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Mechanistic insights into HPV-positivity in non-smokers and HPV-negativity in smokers with head and neck cancer.
Front Oncol
January 2025
Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Schleswig-Holstein, Kiel, Germany.
Introduction: Several aspects of the involvement of HPV in the pathogenesis of HPV-associated diseases remain poorly understood including mechanistic aspects of infection and the question of why the majority of HPV-positive HNSCC-patients are non-smokers, whereas HPV-negatives are smokers. Our previous research, based on 1,100 patient samples, hypothesized an explanation for this phenomenon: Smoking induces upregulation of a mucosal protective protein (SLPI), which competes with HPV for binding to Annexin A2 (AnxA2), pivotal for HPV cell entry. Here we investigate the mechanistic aspects of our hypothesis using transfection assays.
View Article and Find Full Text PDFClinicopathological Features, Epidermal Growth Factor Receptor (EGFR) Mutations and Anaplastic Lymphoma Kinase (ALK) Rearrangement-Based Survival of Patients With Advanced Non-small Cell Lung Cancer in a Tertiary Care Setting.
Cureus
December 2024
Clinical Research, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, PAK.
Background Lung cancer is the most frequent cause of cancer-related deaths and the most common type of cancer globally. It is generally classified into two main histologic subtypes: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). NSCLC is the most prevalent type and is enriched with genetic and molecular diversity.
View Article and Find Full Text PDFReal-world effectiveness of mepolizumab in Japanese asthma patients with diverse backgrounds: Improvements in rhinosinusitis imaging (J-Real-Mepo).
Allergol Int
January 2025
Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan.
Background: Although randomized controlled trials (RCT) have demonstrated the efficacy of mepolizumab for asthma, they have excluded certain patient subgroups. To bridge the gap between RCT and real-world practice, the effectiveness of mepolizumab in a diverse population, including those potentially excluded from RCT, was assessed. Its effects on imaging findings and symptoms of chronic rhinosinusitis (CRS) with asthma were also assessed.
View Article and Find Full Text PDFPersistent symptoms and clinical findings in adults with post-acute sequelae of COVID-19/post-COVID-19 syndrome in the second year after acute infection: A population-based, nested case-control study.
PLoS Med
January 2025
Division of Infectious Diseases, Department of Medicine II, Medical Centre and Faculty of Medicine, Albert-Ludwigs-University, Freiburg, Germany.
Background: Self-reported health problems following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are common and often include relatively non-specific complaints such as fatigue, exertional dyspnoea, concentration or memory disturbance and sleep problems. The long-term prognosis of such post-acute sequelae of COVID-19/post-COVID-19 syndrome (PCS) is unknown, and data finding and correlating organ dysfunction and pathology with self-reported symptoms in patients with non-recovery from PCS is scarce. We wanted to describe clinical characteristics and diagnostic findings among patients with PCS persisting for >1 year and assessed risk factors for PCS persistence versus improvement.
View Article and Find Full Text PDFLong-term smoking contributes to aging frailty and inflammatory response.
Biomol Biomed
January 2025
China Tobacco Sichuan Industrial Co., Ltd., Chengdu, China; Harmful Components and Tar Reduction in Cigarette Key Laboratory of Sichuan Province, Chengdu, China; Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
In recent years, the health challenges linked to frailty in the elderly, particularly those worsened by cigarette smoke, have become more pronounced. However, quantitative studies examining the impact of smoking dosage on frailty in this population remain limited. To address this gap, we developed a model using smoke-exposed elderly mice.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!